IOVA – Iovance Biotherapeutics Inc

Iovance Biotherapeutics, Inc. 是一家新兴的生物技术公司,专注于培养细胞,使用自体肿瘤浸润淋巴细胞(TIL)治疗转移性黑色素瘤等实体瘤的细胞治疗方法的发展和商业化。该公司于2007年9月17日在内华达州成立。

中文介绍: https://xueqiu.com/S/IOVA

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient’s immune system to eradicate cancer cells. It’s lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma.

英文介绍: https://www.morningstar.com/stocks/xnas/iova/quote

主题测试文章,只做测试使用。发布者:star,转转请注明出处:http://wallstreetgm.com/iova-iovance-biotherapeutics-inc/

发表评论

邮箱地址不会被公开。 必填项已用*标注